Canada markets closed

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.3700+0.1400 (+4.33%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 235.50M
Enterprise Value 211.64M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)15.33
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.41

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3167.46%
S&P500 52-Week Change 326.33%
52 Week High 34.2600
52 Week Low 30.9100
50-Day Moving Average 32.8160
200-Day Moving Average 32.3545

Share Statistics

Avg Vol (3 month) 3136.69k
Avg Vol (10 day) 3167.42k
Shares Outstanding 569.88M
Implied Shares Outstanding 669.88M
Float 866.27M
% Held by Insiders 14.57%
% Held by Institutions 111.41%
Shares Short (Aug 30, 2024) 4624.71k
Short Ratio (Aug 30, 2024) 46.5
Short % of Float (Aug 30, 2024) 40.93%
Short % of Shares Outstanding (Aug 30, 2024) 40.89%
Shares Short (prior month Jul 31, 2024) 41.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.15%
Return on Equity (ttm)-108.43%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.66M
Net Income Avi to Common (ttm)-29.34M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.02M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)164.27k
Total Debt/Equity (mrq)1.07%
Current Ratio (mrq)2.39
Book Value Per Share (mrq)0.22

Cash Flow Statement

Operating Cash Flow (ttm)-21.58M
Levered Free Cash Flow (ttm)-11.63M